1. Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review

   • Dilek Aygin
   • Hande Cengiz

   Review Article 02 May 2018 Pages: 497 - 505

   

2. Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies

   • Dorota Kwapisz

   Review Article 26 April 2018 Pages: 506 - 516

3. Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives

   • Md. Sadikuj Jaman
   • Md. Abu Sayeed

   Review Article 03 May 2018 Pages: 517 - 528

   

4. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines

   • Won Hye Ka
   • Seok Keun Cho
   • Jong Cheol Ahn

   Original Article 07 March 2018 Pages: 529 - 538

   

5. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan

   • Akiyo Yoshimura
   • Seiko Okumura
   • Hiroji Iwata

   Original Article 08 March 2018 Pages: 539 - 546

   

6. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions

   • Reginald M. Gorczynski
   • Nuray Erin
   • Laura Y. Gorczynski

   Original Article 12 March 2018 Pages: 547 - 559

   

7. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma

   • Yayoi Adachi
   • Masataka Sawaki
   • Hiroji Iwata

   Original Article 13 March 2018 Pages: 560 - 565

   

8. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line

   • Hiroki Wakabayashi
   • Takahiko Hamaguchi
   • Akihiro Sudo

   Original Article 19 March 2018 Pages: 566 - 574

   

9. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker

   • Naomi Sakamoto
   • Eisuke Fukuma
   • Yoshitomo Koshida

   Original Article 23 March 2018 Pages: 575 - 582

   

10. Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery

    • Madoka Iwase
    • Masataka Sawaki
    • Hiroji Iwata

    Original Article 04 April 2018 Pages: 583 - 589

    

11. Improvement in diagnostic performance of breast cancer: comparison between conventional digital mammography alone and conventional mammography plus digital breast tomosynthesis

    • Ryoko Ohashi
    • Michinobu Nagao
    • Shuji Sakai

    Original Article 12 April 2018 Pages: 590 - 596

    

12. Applying new Magee equations for predicting the Oncotype Dx recurrence score

    • Maher Sughayer
    • Rolla Alaaraj
    • Ahmad Alsughayer

    Original Article 24 April 2018 Pages: 597 - 604

    

13. HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

    • Hitomi Sakai
    • Junji Tsurutani
    • Kazuhiko Nakagawa

    Original Article Open access 26 April 2018 Pages: 605 - 613

    

14. Pseudocirrhosis after chemotherapy in breast cancer, case reports

    • Tomoyoshi Aoyagi
    • Kazuaki Takabe
    • Hiroshi Matsuzaki

    Case Report 25 April 2018 Pages: 614 - 618

    

15. LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH

    • Qing Li
    • Haifeng Gao
    • Yuting Liao

    Rapid Communication 06 April 2018 Pages: 619 - 625

    

16. Current status of postmastectomy radiation therapy in T1–2 breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology Group Survey

    • Shinsuke Sasada
    • Tadahiko Shien
    • Hiroji Iwata

    Letter to the Editor 23 March 2018 Pages: 626 - 627